Inhalation-Aligned Assessment of Airborne Mycotoxin Exposure in Indoor Environments
A structured framework translating exposure-aligned domain principles into field implementation for inhalation-focused airborne sampling.
This framework represents Part C of a three-part analytical series (A–C), operationalizing the domain architecture established in Part B into inhalation-aligned airborne assessment procedures for occupied indoor environments.
Purpose
Part C operationalizes inhalation-aligned airborne mycotoxin exposure assessment within the Exposure-Aligned Analytical Domain Framework (EADF-IM). It defines how airborne measurements should be configured, positioned, and interpreted when the environmental question concerns indoor air–mediated exposure.
This framework establishes the implementation logic required to preserve Airborne Domain alignment during environmental assessment. It translates domain architecture and hazard-class principles into field-applicable sampling configuration, placement constraints, and interpretive boundaries for inhalation-focused investigations.
Scope
This framework defines the evidentiary conditions under which airborne mycotoxin measurements validly represent inhalation-relevant exposure in occupied indoor environments. It specifies breathing-zone alignment, inhalable-fraction capture, temporal definition, and domain-consistent interpretation as core requirements for exposure-aligned airborne assessment.
Part C addresses airborne sampling configuration, room-selection strategy, placement integrity, environmental documentation, and domain-bounded interpretation of airborne results.
What This Framework Does Not Do
Part C does not redefine analytical domain architecture, hazard-class separation, or domain non-equivalence principles established in Parts A and B. It does not evaluate specific sampling technologies, validate analytical platforms, establish exposure thresholds, define clinical interpretation criteria, or prescribe remediation or clearance protocols.
This framework is not a regulatory standard, medical diagnostic instrument, or professional practice requirement. It is intended to support scientifically aligned airborne mycotoxin exposure assessment when inhalation is the investigative hypothesis.
Relationship to Related Frameworks
This page presents the inhalation-aligned airborne implementation layer of the Analytical Domain Alignment series. It specifies how airborne sampling must be configured and interpreted to preserve exposure alignment when the Airborne Domain serves as the evidentiary basis for environmental assessment.
The physicochemical divergence of biological indicators and mycotoxins across environmental phases is defined in Part A. The exposure-aligned analytical domain framework governing interpretation across airborne, dust, and surface media is formalized in Part B. Part C operationalizes those established principles for inhalation-aligned airborne mycotoxin exposure assessment within occupied indoor environments.
Canonical Reference
The complete scientific treatment of inhalation-aligned airborne assessment is presented in the Part C technical white paper:
Ritacco, M. (2026). Operationalizing the Exposure-Aligned Analytical Domain Framework for Indoor Mycotoxins (EADF-IM): Mechanistic Foundations and Field Implementation of Inhalation-Aligned Airborne Assessment in Indoor Environments. Respirare Labs Technical White Paper.
Canonical URL
/preprints/2026c-inhalation-aligned-mycotoxin/
Related Frameworks
Physicochemical Divergence of Biological Indicators and Mycotoxins Across Airborne, Dust, and Surface Analytical Domains in Indoor Environments
/preprints/2026a-mycotoxin-domain-divergence/
An Exposure-Aligned Analytical Domain Framework for Interpreting Mycotoxin Measurements Across Airborne, Dust, and Surface Media in Indoor Environments
/preprints/2026b-mycotoxin-exposure-framework/
Classification
This framework is cataloged within the Analytical Domain Alignment in Environmental Mycotoxin Interpretation series (Parts A–C). It represents the inhalation-aligned implementation layer of the trilogy, translating domain architecture principles into operational airborne assessment strategy.
Interpretive Guide
For a plain-language explanation of how this framework applies to real-world airborne mycotoxin exposure assessment and how to align sampling decisions with inhalation-focused environmental questions, see the Part C Interpretive Guide.